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Resolution of acute and chronic viral infections
requires activation of innate cells to initiate andmain-
tain adaptive immune responses. Here we report that
infection with acute Armstrong (ARM) or chronic
Clone 13 (C13) strains of lymphocytic choriomeningi-
tis virus (LCMV) led to two distinct phases of innate
immune response. During the first 72 hr of infection,
dendritic cells upregulated activation markers and
stimulated antiviral CD8+ T cells, independent of viral
strain. Seven days after infection, there was an
increase in Ly6Chi monocytic and Gr-1hi neutrophilic
cells in lymphoid organs and blood. This expansion
in cell numbers was enhanced and sustained in C13
infection, whereas it occurred only transiently with
ARM infection. These cells resembled myeloid-
derived suppressor cells and potently suppressed
T cell proliferation. The reduction of monocytic cells
in Ccr2/ mice or after Gr-1 antibody depletion
enhanced antiviral T cell function. Thus, innate cells
have an important immunomodulatory role through-
out chronic infection.
INTRODUCTION
A fundamental feature of chronic viral infections, such as during
HIV or HCV infection, is the generalized suppression of the host
immune response. Innate immune responses to viral infections
are essential for initiating the adaptive immune responses
required for the resolution of infection and generation of long-
lasting immunity. Some viral infections fail to elicit sufficient
immune responses or subvert host defenses, thus allowing their
spread and eventual persistence. The ARM and C13 strains of
LCMV have been studied for decades as models for acute and
chronic infections, respectively (Ahmed et al., 1984). These
strains are very closely related genetically, but the ARM strain
leads to a strong CD8+ T cell response that rapidly clears the
virus and provides long-lasting immunity (Butz and Bevan,
1998; Wherry et al., 2003b). Conversely, infection with the C13
strain of LCMV impairs virus-specific T cells, diminishing theirfunction and enabling the persistence of the virus (Wherry
et al., 2003a). Infection with C13 also leads to the suppression
of additional immune responses to viral infections (Borrow
et al., 1995; Sevilla et al., 2000).
The genome of C13 differs from ARM by two coding muta-
tions, one in the glycoprotein (GP) and one in the polymerase
protein L (Ahmed et al., 1988; Matloubian et al., 1993). The GP
mutation enhances the affinity of this protein for the cellular
receptor a-dystroglycan (aDG), leading to greater infection of
aDG-expressing cells such as macrophages, dendritic cells
(DCs), and fibroblastic reticular cells (FRCs) (Matloubian et al.,
1993; Mueller et al., 2007; Smelt et al., 2001). The mutation in
the L protein correlates with higher levels of viral replication in
plasmacytoid DCs (pDCs) and increased early viremia
(Bergthaler et al., 2010). Thesemutations as well as similar muta-
tions in related LCMV strains have been implicated as causing
the persistence of chronic LCMV strains.
Acute LCMV infection rapidly induces DCs to upregulate the
expression of costimulatory markers and gain T cell stimulatory
capacity in a largely type I interferon (IFN-I)-dependent manner
(Montoya et al., 2005). LCMV-specific T cell responses are also
highly dependent on IFN-I with maximal CD8+ T cell proliferation
requiring IFN-I signaling (Thompson et al., 2006). However,
LCMV nucleoprotein (NP) inhibits IFN-I production in infected
cells and persistent LCMV infection inhibits IFN-I production
by pDCs (Martı´nez-Sobrido et al., 2006; Zuniga et al., 2008).
IFN-I-induced STAT2 signaling inhibits the development and
proliferation of DCs (Hahm et al., 2005; Sevilla et al., 2004).
PD-1-PD-L1 signaling, IL-10, and TGF-b are additional immuno-
regulatorymechanisms linked to the persistence of C13 infection
and the exhaustion of the CD8+ T cell response (Barber et al.,
2006; Brooks et al., 2006; Tinoco et al., 2009). Despite these
advances, the innate immune events that occur during the very
earliest hours of infection with LCMV ARM or C13 have not
been studied. Furthermore, although there have been reported
defects in antigen-presenting cell (APC) function during the
chronic stages of C13 infection, whether such defects precede
and cause dysfunctional T cell responses and enable persis-
tence is unclear.
We hypothesized that ARM or C13 induce distinct types of
innate immune responses within the first few hours of infection,
which result in the differential induction of T cell immunity and
viral persistence. To address this issue, we undertook a detailedImmunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc. 309
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Innate Immunity to Acute and Chronic Viral Infectioncharacterization of the kinetics of the innate immune responses
to chronic and acute LCMV infection with a view to identifying
early correlates and mechanisms of adaptive immune exhaus-
tion and viral persistence. Two temporally distinct phases of
innate immune response were observed: an early DC response
during the first 72 hr of infection and a later myeloid cell prolifer-
ation peaking at day 14 postinfection (p.i.). We found the innate
response within the first 72 hr, as assessed by the numbers and
activation status of DC and APC subsets and cytokine produc-
tion, was largely independent of the strain of LCMV. Later during
infection, as CD8+ T cell responses begin to peak, there was
a large expansion of myeloid cell numbers. This expansion was
identical between acute and chronic strains of LCMV until about
day 7. After this period, there was a rapid decline in the numbers
of myeloid cells in ARM-infected mice. During C13 infection,
however, there was a sustained expansion of myeloid cells
that exhibited the phenotype and suppressive function of
myeloid-derived suppressor cells (MDSCs). Diminished recruit-
ment of these cells or the elimination of these cells during chronic
infection by depleting antibody enhanced the function of ex-
hausted T cells. Our findings demonstrate different phases of
innate cell function during viral infection and highlight an impor-
tant role for innate cell inhibition of adaptive immune responses
during chronic infection.
RESULTS
Innate Cell Activation during First 72 hr Is Strain
Independent
The innate immune responses during the first few hours of acute
and chronic LCMV infection remain to be described. To address
this, we performed a detailed kinetic analysis of the various
subpopulations of APCs, as well as induction of innate immune
cytokines, within the first 72 hr of infection. We directly
compared innate activation to infection outcome after ARM
and C13 intravenous infection at 2 3 106 p.f.u. With an 11-
parameter flow cytometry panel, we identified multiple innate
cell populations and gauged their activation by expression of
costimulatory and inhibitory markers.
After gating on live, singlet-discriminated cells, we then iden-
tified lymphocytes by expression of NK1.1, CD19, B220, and
Thy1.2 (Figure S1A available online). In accord with previous
reports (Montoya et al., 2005), there was a trend for the cellularity
of LCMV-infected spleens to decrease during the first 3 days of
infection with both LCMV strains (Figure S1B). There was also
a trend for the numbers of B, CD4+, and CD8+ T cells to decrease
during the first 72 hr.
Having removed the lymphocyte lineage from our gating, we
characterized the various DC populations (Figures S1C and
S1D). pDCs can produce high amounts of IFN-I in response to
viral infections or exposure to foreign nucleic acids (Diebold
et al., 2003; Jung et al., 2008), and during the first few days of
LCMV infection, pDCsproduce prodigious amounts of IFN-a (Zu-
niga et al., 2008). In mice, pDCs can be identified as CD11clo,
B220+, Ly6C+, and CD11b (Figure S1C; Asselin-Paturel et al.,
2001). We observed a reduction in pDCs between 12 and 25 hr
after LCMV infection but pDC numbers typically rebounded
around 42 hr p.i. (Figure S1E). There was no difference in pDC
numbers between ARM and C13 infection.310 Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc.The two major murine splenic conventional DC (cDC) popula-
tions, CD8 and CD8+, were identified from total nonlympho-
cytes by high expression of CD11c and lack of Ly6C (Figure S1D).
CD8 DCs were reduced to about one-quarter of their initial
number during the first 72 hr of infection (Figure S2C). CD8+
DCs cross-present antigens phagocytosed from the environ-
ment via MHC class I and are potent initiators of Th1 cell
responses (den Haan et al., 2000; Pulendran et al., 1999). In
the spleen, LCMV infection leads to a substantial reduction in
the numbers of these cells by day 3 of infection with either strain
(Figure S2C).
Total myeloid cells were identified as CD11clo/ and CD11b+
and were subdivided into three main populations: Gr-1loLy6-
CloF4/80+SSChi eosinophils, Gr-1loLy6ChiF4/80+SSClo mono-
cytic cells, and Gr-1hiLy6CintF4/80SSCint neutrophilic cells
(Figure S1F). Over the first 2 days, there was a trend for eosino-
phil, monocytic cell, and neutrophilic cell numbers to be lower
during the first 24–48 hr of infection before rebounding by day
3 (Figure S1H).
We then determined the activation status of the DC subsets.
cDCs expressed higher levels of CD80, CD86, and MHC class
II molecule I-Ab at 25 hr p.i. compared to pDCs (Figure 1A).
CD8+ DCs and CD8 DCs were both robustly activated and ex-
pressed high CD80 and I-Ab. However, activation was transient
and substantially reduced by day 3. In contrast, pDCs did not
upregulate CD80 or I-Ab and expression of CD86 was less
than that of cDC expression. Among the major myeloid cell pop-
ulations, only the monocytic cells showed any appreciable
expression of the costimulatory marker CD86 (data not shown).
Activation marker expression on all cell types was independent
of the viral strain.
Furthermore, the inhibitory receptors PD-L1 and PD-L2
(Barber et al., 2006; Chen, 2004; Sharpe and Freeman, 2002)
were also induced by infection. PD-L1 expression was increased
on most cell types examined after LCMV infection. The kinetics
of PD-L1 upregulation was indistinguishable between ARM and
C13. The expression of PD-L2 was restricted to CD8+ DCs but
was present at only very low levels on these cells.
With intracellular cytokine staining, IL-12p40 and TNF were
readily detectible in cDC populations over the first day of
LCMV infection (Figure 1B and data not shown), consistent
with previous studies (Montoya et al., 2005). DC-produced
IL-12 was detectible between 12 and 48 hr p.i., with CD8+
DCs having the highest amounts of IL-12. TNF was tran-
siently produced by CD8+ DCs during infection with similar
kinetics as IL-12 (data not shown). Cytokine production by
cDCs was not significantly different between acute and chronic
infection.
We then assessed cytokines in the serum of LCMV-infected
mice. Large amounts of IFN-a were readily detected in the
sera, as early as 24 hr, in mice infected with either ARM or C13
(Figure 1C). In contrast, IFN-g was detectable only at 72 hr (Fig-
ure 1C). Furthermore, at 25 hr p.i., IFN-induced chemokines
CCL2, CXCL9, and CXCL10 were readily detectable (Figure 1C).
Again, induction of these innate cytokines and chemokines was
nearly identical in both ARM and C13 infection. Thus, these
results indicate, as assessed by the aforementioned parameters,
that innate responses to LCMV infection during the first 72 hr
were independent of viral strain.
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Figure 1. The Kinetics of APC Activation and Innate Cytokine Production Are LCMV Strain Independent
(A) The normalized MFI of activation markers on DC populations relative to isotype control during early LCMV infection. Data are represented as mean ± SEM of
three experiments with three pooled spleens for each time point.
(B) Representative intracellular staining for IL-12p40 of splenocytes over indicated time. Numbers in the quadrant represent percent cytokine expression in cDCs
from LCMV-infected mice.
(C) Serum IFN concentrations in naive and LCMV-infected mice as quantified by ELISA. Data are represented as mean ± SEM of three independent experiments
with three mice per time point.
(D) Serum chemokine levels in naive and LCMV-infected mice as quantified by luminex bead assay. Data are represented as mean ± SEM and are representative
of two independent luminex assays of serum pooled from three mice and analyzed in duplicate.
See also Figure S1.
Immunity
Innate Immunity to Acute and Chronic Viral InfectionMyeloid Cells from C13-Infected Mice Show Impaired
CD8+ T Cell Priming
Next, we determined the stimulatory capacity of APCs from
LCMV-infected spleens. CD11c+ DCs and CD11cCD11b+
myeloid cells isolated from the spleens 24 or 48 hr p.i. were
cultured with OVA-specific CD8+ cells from OT-I mice and
SIINFEKL peptide for 3 days. Both populations stimulated T cell
proliferation with as little as 0.5 pg/ml peptide (Figure 2A and
data not shown). DCsweremore potent stimulators thanmyeloid
cells and were capable of inducing similar T cell proliferation with
1/10 the number of APCs. Importantly, APCs from ARM and C13
infection demonstrated nearly identical stimulatory ability.
DCs andmyeloid cells from day 7 p.i. induced equivalent T cell
proliferation, regardless of LCMV strain (Figure 2B). Unexpect-edly, at day 14 p.i., although DCs from all groups were fully
capable of stimulating T cells, myeloid cells from C13 infection
were unable to effectively stimulate T cell proliferation. In fact,
virtually no CD8+ T cells seemed to survive culture, regardless
of the concentration of antigenic peptide used. In contrast,
myeloid cells from ARM-infected spleens induced slightly lower
proliferation than did myeloid cells from uninfected mice,
although this was evident in only some of the experiments (Fig-
ure 2C). This deficit in proliferation was overcome by adding
higher concentrations of peptide.
We measured the viral loads in the CD11c+ and CD11c
CD11b+ subsets on day 14 after C13 infection to determine
whether the reduced immune stimulatory capacity of themyeloid
cells was a consequence of enhanced viral loads in these cellsImmunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc. 311
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Figure 2. CD8+ T Cell Stimulatory Capacity of APCs from LCMV-Infected Mice
(A) Total proliferating CFSE-labeled OT-I T cells after culture with CD11c+ DCs or CD11cCD11b+ myeloid cells at 24 hr p.i. Proliferation was measured by flow
cytometry after 3 days of culture with different amounts of SIINFEKL peptide.
(B and C) Total DCs and myeloid cells from day 7 p.i. (B) or day 14 p.i. (C) were bead purified and cultured with purified OVA-specific OT-I T cells as in (A).
Data are representative of three (A) or two (B, C) experiments. See also Figure S2.
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Innate Immunity to Acute and Chronic Viral Infectioncompared to DCs. We found that both populations contained
measurable infectious virus, though DCs contained roughly
203 more virus than an equivalent number of myeloid cells
from day 14 p.i. with C13 (data not shown). Thus, although
both DCs and myeloid cells contain virus during chronic infec-
tion, only myeloid cells lose their ability to stimulate T cells.
Chronic LCMV Infection Induces Enhanced and
Sustained Myeloid Cell Expansion
To better understand the impaired stimulatory capacity of the
CD11cCD11b+ myeloid cell population during C13 infection,
we determined the cellular composition of this population during
infection. At day 7 p.i., when the ARM- and C13-derived myeloid
cells were equally stimulatory (Figure 2), the composition of the
myeloid cells was virtually identical between infections (Fig-
ure S2A). However, at day 14 p.i., the ratio of eosinophils to
monocytic cells was substantially greater in ARM-infected
mice relative to myeloid cells from C13-infected mice (Fig-
ure S2B). Theweakly stimulatorymyeloid cell population isolated
at day 14 during C13 infection consisted almost entirely of mono-
cytic and neutrophilic cells.
We then evaluated myeloid cell populations over 3 weeks of
infection. Total splenic CD11b+ myeloid cells, defined as
described in Figure S1, increased during ARM and C13 infection
between days 3 and 7, reaching about a 4-fold expansion above
what was observed in uninfected mice (Figure 3A). Myeloid cell
numbers in ARM-infected mice began contracting around day
10, reaching baseline numbers by day 21. In contrast, these cells
continued to increase with C13 infection, peaking between days
14 and 21 with nearly 10-fold more myeloid cells than in naive
mice (Figure 3A).312 Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc.Both monocytic and neutrophilic myeloid cell populations
were expanded during ARM and C13 infection (defined in Fig-
ure S1). Monocytic cell expansion peaked between days 5 and
7 in the spleen and blood (Figure 3B and data not shown). After
day 10 of ARM infection, the monocytic cells began contracting,
reaching naive levels by day 14. C13 infection led to sustained
numbers of monocytic cells (about 10-fold higher than naive
mice), which persisted for up to 3 weeks. Neutrophilic cells
also peaked in the spleen and blood on day 7 p.i. before con-
tracting in ARM-infected animals (Figure 3B and data not
shown). In contrast, neutrophilic cells continued to increase
during C13 infection, reaching numbersmore than 20-fold above
naive levels before contracting.
On day 14 p.i., the number of both monocytic and neutrophilic
cells were significantly higher in the spleen, blood, and periph-
eral lymph nodes (pLNs) of C13-infected mice compared to
naive or ARM-infected mice (Figure 3C and data not shown).
Histology of spleens from the peak of myeloid cell expansion
during C13 infection shows a higher proportion of F4/80+
myeloid cells and a corresponding loss of lymphoid-follicle
structure consistent with previous reports (Figure 3D; Odermatt
et al., 1991).
Monocytic Cells Expanded during C13 Infection
Resemble MDSCs
The expression of phenotypic and activation markers onmyeloid
cells was examined during C13 and ARM infections. Spleen
monocytic cells did not show differences in expression of
CD86 and I-Ab; however, PD-L1 expression remained elevated
in C13-infected mice while subsiding during ARM infection.
CD80 expression was also elevated on monocytic cells in
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Figure 3. Enhanced and Sustained Expansion of Myeloid Cells during Chronic LCMV Infection
(A) Total splenic CD11b+ myeloid cells during the first 24 days of ARM and C13 infection were enumerated by flow cytometry and the fold increase over naive
levels was determined. Data are representative of three experiments and each point represents three pooled spleens.
(B) The number of monocytic and neutrophilic cells in the spleen of LCMV-infected mice. Data are representative of at least three experiments and each point is
the mean ± SEM of three pooled spleens.
(C) Total number of monocytic and neutrophilic myeloid cells in the spleen of naive and day 14 LCMV-infected mice. Data are individual mice from four to six
experiments and the bar represents the median. *p < 0.05, **p < 0.01, ***p < 0.001.
(D) Representative histology of mouse spleens from naive and day 14 LCMV-infected mice. B220+ B cells are green, Thy1.2+ T cells are red, and F4/80+ myeloid
cells are blue.
Immunity
Innate Immunity to Acute and Chronic Viral Infectionlymphoid tissues and in the blood at the peak of the myeloid cell
expansion during chronic infection (Figures 4A and 4B). In addi-
tion, the CSF-R (CD115), which has been shown to be expressed
on MDSCs in tumor models (Huang et al., 2006; Yang et al.,
2006), was expressed on the monocytic cells in C13-infected
mice (Figure 4C). Neutrophilic cells increased expression of
PD-L1 but not CD80, CD86, I-Ab, or CD115 during ARM or C13
infection (data not shown).
Sorted monocytic cells from day 14 after C13 infection were
very similar inmorphology to naive sortedmonocytes (Figure 4D).
Neutrophilic cells from day 14 C13-infected spleens showed less
lobation and were predominantly in band form, representing
a less mature state and further suggesting that these cells are
immature myeloid cells (Figure 4D).
We then performed microarray gene expression analysis on
monocytic cells sorted from naive and day 14 ARM- or C13-in-
fected spleens to obtain insights into the regulatory networks
that control the functions of these cells. Monocytic cells from
C13-infected mice expressed many genes, such as Trem1,
Cd33, Ly6c1, Ptgs1, Ptgse, and Sell (encoding CD62L), which
are known to be associated with MDSCs (Figure 4E; Gabrilovichand Nagaraj, 2009). In addition, there was increased expression
of Cd274 (PD-L1), Kit, S100a8, S100a9, and Birc5 during both
LCMV infections.
We then sought to profile the expression of genes that would
give insight to the function of monocytic cells during C13 infec-
tion. Transcripts for inflammatory chemokines CXCL9 and
CXCL10 were increased during both ARM and C13 infection
but increases in CCL2, IL-7, CSF-1, and IL-27 cytokine tran-
scripts above naive levels were unique to C13 infection (Fig-
ure 4E). ARM and C13 infection also increased expression of
genes that encode CCR5, IL-1R2, IL-28R, and IL-18R and
decreased CX3CR1, IL-6, IL-10, CSF-1, and VEGF receptor
transcription in monocytic cells. Only C13 infection increased
transcripts for the receptors for IL-8, IL-15, IL-12, IL-20, and
GM-CSF. Monocytic cells during C13 infection showed differen-
tial expression of activation-induced markers, myeloid-macro-
phage markers, homing and recruitment genes, and functional
markers.
Infection with either ARM or C13 induced expression of genes
related to IFN responses. Induction of 20-50 oligoadenylate
synthetase antiviral genes and many other IFN-stimulated genesImmunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc. 313
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Figure 4. Myeloid Cells Expanded during Chronic Infection Resemble MDSCs
(A) Expression of phenotypic markers on monocytic myeloid cells after LCMV infection.
(B) Expression of CD80 by monocytic cells from multiple organs at 14 days p.i.
(C) Kinetics of CD115 expression on total CD11b+ cells and myeloid cells.
Data are representative of three experiments with three pooled spleens per group.
(D) Geimsa staining of sorted monocytic and neutrophilic cells from naive and day 14 C13-infected mice. Data are representative of three independent
experiments.
(E) Relative expression of genes in monocytic cells from ARM- or C13-infected mice compared to naive mice, as determined by Illumina BeadChips. Genes are
ranked by relative expression and represent monocytic cells purified from three independent experiments (mean fold-change).
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Innate Immunity to Acute and Chronic Viral Infectionwere not unique to C13 infection, but there were more of
these types of genes upregulated during chronic infection.
Monocytic cells also upregulated several genes related to
extracellular matrix breakdown and remodeling such as matrix
metallopeptidases, cathepsins, and lamin. These cells also
showed differential expression of approximately 80 genes
related to themitochondrial respiratory burst, including genes in-
volved in the regulation of oxidative stress, both in genes whose
products promote reactive oxygen species (ROS) production
and those that mitigate ROS-related tissue damage. These
ROS-related genes were predominantly induced during chronic
infection. Increased ROS production has been shown to be
one of the main identifiers of MDSCs in multiple tumor and
infection models (Kusmartsev et al., 2004; Zhu et al., 2007).
These data suggest that although monocytic cells from C13-in-
fected mice express many genes that encode proinflammatory
mediators, they also express genes that encode molecules314 Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc.involved in oxidative stress, which is implicated in tolerogenic
responses.
Furthermore, monocytic cells showed a significant increase in
molecules related to the processing and presentation of
peptides on class I MHC. Transcripts for proteosome subunits,
peptide transporters, and MHC class I molecules were all
increased in monocytic cells from C13-infected mice, relative
to cells from naive mice. Conversely, multiple genes related to
MHC class II antigen presentation were downregulated during
C13 infection; transcripts for multiple MHC class II, invariant
peptide, and HLA-DMmolecules were all decreased. In contrast,
monocytic cells from acute infection increased transcription
for only a few class I genes and upregulated some class II-
related genes.
Overall these data reveal a distinctive molecular signature of
monocytic cells isolated from C13-infected mice, relative to
those from ARM-infected or naive mice. Taken together, the
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Figure 5. Monocytic Cells from C13-Infected Mice Suppress CD8+ T Cell Proliferation
(A) Total spleen monocytic cells from ARM- or C13-infected mice were compared to the frequency of IFN-g+ GP33-specific CD8+ T cells.
(B) Flow cytometry-sorted monocytic cells from day 14 after LCMV infection were cultured with OT-I splenocytes in the indicated ratios. Cultures were stimulated
with no peptide, SIINFEKL, or vaccinia (B8R) peptide. Proliferation was determined by [3H]thymidine incorporation. *p < 0.05, **p < 0.01, ***p < 0.001.
(C and D) SortedMDSCs fromC13-infectedmice were cultured 1:2 with purifiedOT-I T cells and stimulated in the presence of NOS or ARG1 inhibitors or blocking
antibodies.
(C) Percent proliferation was calculated relative to stimulated OT-I splenocytes without added MDSCs and mean ± SEM are performed on three independent
experiments.
(D) Proliferation was measured by CFSE dilution after 3 days of culture. Data are representative of three independent experiments.
Immunity
Innate Immunity to Acute and Chronic Viral Infectionphenotypic, morphological, and transcriptional signatures
suggest that myeloid cells from C13-infected mice resemble
MDSCs.
Myeloid Cells Suppress T Cell Proliferation Ex Vivo
MDSCs that expand during multiple tumor models can potently
suppress T cell responses (Youn et al., 2008). The substantial
increase of myeloid cells during chronic LCMV infection coin-
cided with the functional exhaustion of LCMV-specific CD8+
T cells (Figure 5A), raising the possibility that myeloid cells sup-
pressed LCMV-specific CD8+ T cells.
To determine whether these cells were immunosuppressive,
we sorted purified monocytic cells and cocultured them with
total splenocytes from OT-I mice and stimulated with SIINFEKL
peptide. Monocytic cells from day 14 after C13 infection sup-
pressed OT-I T cell proliferation in a cell number-dependent
manner (Figure 5B). Naive and ARM-derived myeloid cells had
no effect on the proliferation of the T cells even at high ratios.
Monocytic cells from C13-infected mice were also able to
suppress T cell responses in a different system via plate-bound
anti-CD3 and anti-CD28 stimulation of T cells from OT-I mice
(Figures 5C and 5D). Interestingly, however, undivided CD8+T cells seem to survive culture, when plate-bound stimulation
with anti-CD3ε and anti-CD28 was used, presumably because
of survival signals delivered via these receptors to T cells.
Neutrophilic cells could suppress T cell responses when OT-I
cells were used in the presence of SIINFEKL peptide but were
unable to induce suppression in the system with plate-bound
anti-CD3 and anti-CD28 stimulation of T cells (data not shown).
MDSCs from tumor and other models systems have been re-
ported to suppress T cell proliferation by metabolism of L-argi-
nine by inducible nitric oxide synthase (iNOS) and arginase1
(ARG1). To determine the mechanism by which monocytic cells
suppress T cell proliferation, these cells were cultured with CD8+
T cells from OT-I mice, with or without inhibitors against the
aforementioned molecules. With the addition of the iNOS-
specific inhibitor L-NIL or total NOS inhibitor L-NMMA, the prolif-
eration of T cells was restored. Additionally, blocking antibodies
to IFN-g, which is known to induce iNOS (Melillo et al., 1994),
alleviated suppression. Neither the addition of ARG1 inhibitor,
nor-NOHA, or blocking antibodies to IL-10R, TGF-b, or PD-1
were able to restore suppression. Monocytic MDSCs derived
from chronic LCMV infection limit T cell proliferation via IFN-g-
induced iNOS production of NO.Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc. 315
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Figure 6. CCR2-Deficient Mice Have Enhanced T Cell Responses to C13
(A) Serum concentrations of CCL2 were measured during ARM and C13 infection.
(B) Serum concentrations of CCL2 in WT and Ccr2/ mice on day 14 after C13 infection.
(A and B) Serum cytokine concentrations are presented as mean ± SEM fromR3 mice per group.
(C) Representative flow cytometry CCR2 staining on monocytic cells from WT and Ccr2/ mice on day 14 after C13 infection.
(D and E) Blood (D) and spleen (E) levels of monocytic cells on days 7 and 14 after C13 infection were determined by flow cytometry. Data are represented as
mean ± SEM of three to five experiments, each with four to six mice per group.
(F) Spleen CD8+ T cell cytokine production after stimulation with indicated LCMV peptides on day 7 and day 14 p.i. Data are represented as mean ± SEM of three
to four experiments, each withR4 mice per group.
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3.
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Innate Immunity to Acute and Chronic Viral InfectionMobilization of Monocytic Suppressor Cells Is
Dependent on CCR2
The twomajor monocytic cell subsets inmice are typically distin-
guished by their differential expression of chemokine receptors
and other surface markers. ‘‘Classical’’ monocytes have been
described as CCR2+, Ly6Chi, CX3CR1
+, and CD62L+ whereas
‘‘nonclassical’’ monocytes are CCR2, Ly6Cint, CX3CR1
++, and
CD62L (Geissmann et al., 2003). CCL2 is known to be a ligand
for CCR2 and previous studies have demonstrated that the
recruitment of MDSCs to tumors was mediated by CCR2-
CCL2 signaling and that depletion of CCR2+ cells enhanced
antigen-specific CD8+ T cell responses (Huang et al., 2007; Le-
sokhin et al., 2012). We therefore determined whether recruit-
ment of MDSCs during C13 infection was dependent on CCR2.
We first measured the serum concentrations of CCL2
throughout acute and chronic LCMV infection (Figure 6A). Both
ARM and C13 infection led to a high amount of CCL2 at 24 hr
p.i. (Figure 1C). CCL2 concentrations were still significantly
elevated on day 7 p.i. but by day 10 the chemokine concentration316 Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc.had dropped during ARM infection to near-baseline levels. In
contrast, CCL2 concentrations after C13 infection remained
markedly elevated over baseline and ARM levels as late as
28 days p.i.
Upon infection ofWT andCcr2/micewith C13, we observed
that Ccr2/ mice showed significantly increased concentra-
tions of CCL2 in the serum at 14 days p.i. (Figure 6B). Monocytic
cells expanded in the spleen, pLN, blood, and liver were
predominantly CCR2+ at both day 7 and day 14 after C13 infec-
tion (Figure 6C and data not shown). The numbers of monocytic
cells in the blood at these times were significantly lower in C13-
infectedCcr2/mice than infected controls (Figure 6D), despite
the elevated levels of CCL2. This is consistent with previous
reports that Ccr2/ monocytes are defective at migrating from
the bone marrow to the blood (Serbina and Pamer, 2006). Lower
numbers of monocytic cells in the blood of Ccr2/ mice were
evident even 14 days p.i., although the numbers of such cells
in both Ccr2/ and WT mice had increased relative to the
numbers on day 7 (Figure 6D).
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Figure 7. Depletion of Myeloid Cells Enhanced LCMV-Specific T Cell Cytokine Responses
C13-infected mice received 100 mg anti-Gr-1 (RB6-8C5) or isotype control antibody per day starting on day 11 p.i.
(A andB) Total myeloid cells (CD11b+CD11clo/) in the blood (A) and spleen (B) weremeasured by flow cytometry on day 14 p.i. Data are individual mice from three
independent experiments and the bar represents the median.
(C) Frequency of cytokine production in spleen CD8+ T cells after stimulation of splenocytes with indicated LCMV peptides for 5 hr and intracellular flow cytometry
cytokine staining. Data are represented as mean ± SEM from at least three experiments withR5 mice per group.
(D) Total myeloid cells in the pooled total pLNs. Data are averages of total pLNs from three mice in three independent experiments and the bar represents
the median.
(E) Frequency of cytokine production in pLNCD8+ T cells after stimulation with indicated LCMVpeptides for 5 hr and intracellular flow cytometry cytokine staining.
Data are represented as mean ± SEM from three experiments withR5 mice per group. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S4.
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Innate Immunity to Acute and Chronic Viral InfectionIn the spleen, there was a marked reduction in monocytic cell
numbers in Ccr2/mice at day 7 p.i., although at day 14 mono-
cytic cell numbers in Ccr2/ mice had expanded relative to WT
mice (Figure 6E). This suggests that whereas CCR2 plays a key
role in the exit of monocytic cells from the bone marrow to the
blood, it plays little or no role in the migration of such cells
from the blood to the spleen (Serbina et al., 2008). When multiple
lymphocyte and DC populations were measured on day 14 p.i.,
we observed that T cell, pDC, and cDC numbers were equivalent
in the spleen and pLN of B6 and Ccr2/ mice (Figures S3A and
S3B). Only B cells in the spleen of Ccr2/ mice were slightly
diminished compared to those in the spleen of WT mice.
Given the reducednumbers ofmonocytic cells in the spleens of
C13-infectedCcr2/mice at day 7, we assessed themagnitude
of antigen-specific CD8+ T cell responses. Cytokine expression
by CD8+ T cells stimulated ex vivo with three immunodominant
MHC class I peptides were not significantly different in Ccr2/
and B6 mice on day 7 p.i., with the exception of NP396-specific
responses (Figures6FandS3C).However, byday14 thecytokine
responses of LCMV-specific T cells were significantly elevated in
frequency andabsolute number in theCcr2/mice (FigureS3C).
Taken together, these data demonstrate a decreased mobiliza-
tion of monocytic cells from the bone marrow into circulationduring chronic infection of Ccr2/ mice. This diminished pool
of blood monocytic cells delays their recruitment to the spleen,
thereby reducing the number of MDSCs in lymphoid tissues
and decreasing the opportunity for T cell suppression.
Antibody Depletion of Myeloid Cells Enhances LCMV-
Specific T Cell Responses In Vivo
To test specifically whether myeloid cells during C13 infection
inhibit T cell responses and contribute to T cell exhaustion, we
depleted total myeloid cells with an antibody against Gr-1. We
treated mice with 100 mg of anti-Gr-1 for 3 days prior to the
peak of myeloid cell expansion on day 14. It has been previously
reported that anti-Gr-1 does not completely deplete Gr-1+ cells
and leaves a population with the antibody on the surface for
more than 4 days after treatment (Ribechini et al., 2009). Staining
with a secondary antibody recognizing the depleting antibody
confirmed that there was significant occlusion of the Gr-1
epitope (data not shown) that blocked fluorophore-conjugated
RB6-8C5 (Ly6C/G) and 1A8 (anti-Ly6G) antibody staining.
Because of this, we measured total nonlymphocyte, non-DC,
myeloid cells. Treatment with anti-Gr-1 significantly reduced
the total numbers of myeloid cells in the spleen and blood
(Figures 7A and 7B) to levels seen in naive mice. On average,Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc. 317
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Innate Immunity to Acute and Chronic Viral Infectionrelative to untreated mice, antibody-treated mice had 1/10 and
1/6 the number of myeloid cells in the blood and spleen, respec-
tively. By using expression of F4/80 by monocytic cells and
DEC-205 by neutrophilic cells, it was possible to subdivide the
monocytic populations independent of Gr-1 expression. In the
blood and spleen, there was a significant reduction in monocytic
cells, and in the blood, spleen, and pLN there was significant
reduction of neutrophilic cells (Figures S4A and S4B).
The depletion was specific tomyeloid cells with there being no
significant reduction in total lymphocyte and DC numbers in the
spleen or pLN (Figures S4C and S4D). The depletion of myeloid
cells correlated with a significant increase in the frequency of
virus-specific functional T cell responses. Depleted mice
showed increased frequencies and absolute numbers of IFN-
g-, TNF-, and IL-2-producing LCMV-specific T cells in the spleen
(Figures 7C and S4E). These cells were also more polyfunctional
than T cells from untreated mice, having increased proportions
of IFN-g and TNF double-positive cells (data not shown). Myeloid
cells were also reduced by half in the pLN (Figure 7D) and had
a corresponding increase in CD8+ T cell function (Figures 7E
and S4F). There was a trend for viral loads to be reduced after
depletion of myeloid cells, although this was not statistically
significant (data not shown). Our data suggest that by reducing
the numbers of suppressive myeloid cells, we were able to boost
CD8+ T cell function.
DISCUSSION
Diminished CD8+ T cell number and function has been attributed
to the persistence of viral infections in both humans and mice
(Klenerman and Hill, 2005; Zajac et al., 1998). In this study we
show that during the T cell priming phase of LCMV infection,
both ARM and C13 strains activate innate APCs and induce
phenotypic and functional changes with virtually identical
kinetics. After the induction of T cell responses, C13 infection
leads to a massive expansion and accumulation of myeloid cells
with T cell-suppressive function.
Persistently infecting strains of LCMV initially infect marginal
zones by 24 hr p.i., then progress to the interdigitating DCs of
the white pulp by day 3 p.i. In contrast, acutely infecting strains
are restricted to the red pulp of the spleen (Borrow et al., 1995;
Smelt et al., 2001). This difference in tropism has been attributed
to the higher affinity of the viral GP for its cellular receptor, aDG,
which is highly expressed on DCs, and results in a much higher
viral burden in splenic DCs (Sevilla et al., 2000). Our data
suggest that despite these differences, during the first 3 days
of infection, persistent and chronic strains of LCMV similarly
affect the activation and function of innate APCs. The upregula-
tion of activation markers and proinflammatory cytokines by DC
andmyeloid populations during the first 3 days is independent of
viral strain.
Both DC and myeloid cells are capable of stimulating T cell
proliferation and differentiation during the first few days of infec-
tion with acute or chronic LCMV. Addition of exogenous peptide
to APC cultures leads to nearly identical proliferation T cells. It is
important to note that these data do not preclude the possibility
that APCs during acute or chronic infection have different
antigen loads or specific impairments in presenting viral antigens
on MHC molecules.318 Immunity 38, 309–321, February 21, 2013 ª2013 Elsevier Inc.Although we could not demonstrate any functional deficit in
DCs purified from acute or chronically infected mice, we
observed that CD11b+ myeloid cells from chronically infected
mice at 14 days p.i. not only were unable to stimulate T cells,
but they actively suppressed the priming of T cells. Both the
monocytic and neutrophilic cells, profoundly expanded during
C13 infection, had the appearance of MDSCs as described in
multiple models of chronic infection (Gallina et al., 2006; Voisin
et al., 2004; Zhu et al., 2007).
It is important to emphasize that although myeloid cells are
expanded during day 7 after both ARM and C13 infection, these
cells were not observed to be suppressive at this time. Only after
this point do we observe suppression of T cell proliferation by
C13-derived CD11cCD11b+ myeloid cells. We cannot formally
exclude the possibility that early on both infections induce some
suppressive activities in myeloid cells, but C13 infection clearly
leads to the sustained and enhanced suppressive function of
these cells.
Although CCR2 is important to the egress of monocytes from
the bone marrow into the blood, the entry of monocytes into
inflamed tissues is not CCR2 dependent and can happen by
a variety of other receptors, including CCR5 (Serbina and
Pamer, 2006). Indeed, our gene chip data suggest that CCR5
is upregulated on monocytic cells during infection and may be
an alternative mechanism for MDSC accumulation in tissues.
The diminished level of circulating monocytic cells and alterna-
tive egress mechanisms may cause Ccr2/ MDSC entry into
the spleen with slightly delayed kinetics, delaying their suppres-
sive effect on T cells.
Currently there are no known markers specific to murine
MDSC. We have used an antibody recognizing one of the
predominant markers expressed by MDSC, Gr-1, to deplete
myeloid cells expanded during C13 infection. The RB6-8C5 anti-
body clone has been used for years to deplete neutrophils,
monocytes, and MDSCs in a variety of settings (Daley et al.,
2008; Delano et al., 2007; Kim et al., 2009). We used a dose
and regimen of antibody delivery that reduced both neutrophilic
and monocytic cell populations in the blood, spleen, and pLN,
while not significantly decreasing other cell types. The loss of
myeloid cells correlated with enhanced CD8+ T cell function
but surprisingly did not significantly impact viral loads. The failure
to eliminate virus may be due to multiple factors. Although
myeloid cells are infected by C13, they are but one of many
cell types, including DCs and FRCs, that are highly infected by
C13. Thus it was not surprising that the depletion of myeloid cells
did not in itself lower viral loads. We administered antibody
during the window when myeloid cells began to diverge in
ARM and C13 infection, for only 3 days. This is probably insuffi-
cient time for the CD8+ T cells to significantly impact viral loads
and eliminate the signals leading to further MDSC expansion and
function. Additionally, RB6-8C5 can also transmit signals via
STAT1, STAT3, and STAT5 and consequently induce BMmyelo-
poeisis, induce apoptosis in granulocytes, and cause transient
loss of MDSC-suppressive function (Ribechini et al., 2009).
These factors complicate the use of this antibody as a treatment
for chronic LCMV infection. Furthermore, MDSCs may be just
one of several factors (e.g., PD1-PDL1, IL-10, and TGF-b)
involved in the suppression of T cell responses and persistence
of viral infection during C13 infection.
Immunity
Innate Immunity to Acute and Chronic Viral InfectionIt seems that there is no inherent defect in the initial priming
of CD8+ T cells during chronic LCMV infection compared to
acute infection. However, the increased infectivity of DCs,
myeloid cells, and FRCs by persistent strains of LCMV and
their faster replication probably outpaces the ability of the
innate and adaptive immune responses to contain the infec-
tion. In addition to increasing the opportunity for T cells to
receive antigenic stimulation, which drives T cell exhaustion
(Mueller and Ahmed, 2009), widespread C13 infection in-
creases the number and dissemination of infected targets for
CTL killing. CTL lysis of infected cells is the cause of immuno-
pathology during C13 infection and can risk the survival of the
infected animal. After the loss of infected accessory and hema-
topoietic cells to CTL killing, and in response to stimulatory
signals such as CCL2, myeloid progenitor cells are mobilized
from the bone marrow to replace the dead cells. Upon entering
tissues experiencing prolonged inflammation, with both innate
and adaptive effector cytokines present, myeloid precursors
gain a suppressive function. IFN-g produced upon recognition
of viral antigens can induce iNOS production in monocytic cells
and in turn inhibit T cell function. MDSCs, in concert with
multiple suppressive mechanisms, counter the excessive acti-
vation of the innate immune system and immunopathology
caused by the persistence of pathogens during chronic infec-
tions (Medzhitov et al., 2012), but consequently hinder viral
clearance.
The appearance of large numbers of MDSCs during chronic
inflammation appears to be a common feedback mechanism
in both mice and humans. Because of this, many different
avenues of combating MDSC number, function, and generation
are being actively pursued (Gabrilovich and Nagaraj, 2009).
Having implicated MDSCs in the suppression of T cell
responses during LCMV infection, and demonstrating that
depletion of these cells can enhance T cell function, we believe
that counteracting MDSC effects is likely to be an important
additional way to confront difficulties in treating chronic human
infections like HIV and HCV. Taken together, the data presented
in this study highlight the polyphasic nature of the innate
responses to viral infections and reveal a continuing role for
the innate immune system throughout the course of persistent
viral infections.
EXPERIMENTAL PROCEDURES
Mice and Viruses
C57BL/6 (Charles River Laboratory), OT-I (Rag1/2+/+), Ccr2/ B6.129S4-
Ccrtm1Ifc/J (The Jackson Laboratory), B6.129S7-Rag1tm1Mom Tg(TcraTcrb)
1100Mjb N9+N1(OT-I(Rag1/)) (Taconic) mice were maintained under
specific-pathogen-free conditions in the Emory Vaccine Center vivarium. All
of the animal protocols were reviewed and approved by the Institute Animal
Care and Use Committee of Emory University. LCMV strains ARM and C13
from R. Ahmed and J. Jacob (Emory Vaccine Center, Emory University,
Atlanta, GA) were grown and quantified as described (Ahmed et al., 1984;
Borrow et al., 1995).
Flow Cytometry
Spleens from naive and LCMV-infected mice were collagenase digested as
described (Dillon et al., 2006). Collagenase-digested splenocytes were stained
with multiple mAb and samples were acquired on a BD Biosciences LSR II and
analyzed with FlowJo (TreeStar). Geometric mean fluorescence intensities of
activation markers were normalized to nonspecific isotype controls. Thenormalization was calculated as (gMFImarker  gMFIisotype)/gMFIisotype. Further
details are in Supplemental Information.
Serum Cytokine Analysis
Serum pooled from three mice was assayed with Bio Rad and Invitrogenmulti-
cytokine detection panels. Data were acquired with the Luminex 100 reader
and analyzed with Masterplex Quantitation software (Miraibio). ELISAs were
performed for IFN-g (eBioscience), IFN-a (PBL InterferonSource), and CCL2
(R&D Systems).
APC Functional Assays
Total DCs and myeloid cells were purified from the collagenase-digested
spleens of infected mice at 24 hr, 7 days, and 14 days p.i. Splenocytes were
depleted with anti-CD19-coated microbeads (Miltenyi) then positively
selected by anti-CD11c+ microbeads. Total myeloid cells were purified from
the CD11c fraction by using anti-CD11b+ microbeads. Total DC and myeloid
cell populations were determined as >95% pure by flow cytometry.
Purified DCs or myeloid cells were cultured with 105 CFSE-labeled CD8+
OT-I T cells at a ratio of 1:10 or 1:1, respectively. Cells were cultured with
SIINFEKL peptide (a generous gift from J. Pohl, Biotechnology Branch,
CDC, Atlanta, GA) for 3 days before being stained with anti-CD8 and anti-
Thy1.2 (BD PharMingen) and analyzed on an LSR II flow cytometer.
T Cell Suppression Assay
Total CD11b+ cells were enriched from the spleens of five naive or day 14
LCMV-infected mice via MACS beads before being sorted on a FACS Aria II
(BD Biosciences) into Ly6ChiGr-1int and Ly6CintGr-1hi populations. The
average purity of monocytic cell populations from three experiments was
>93%. Myeloid cells were added to 105 OT-I responder splenocytes and
cultured for 24 hr with SIINFEKL or control vaccinia peptide (B8R) before
[3H]thymidine was added and proliferation was evaluated as previously
described (Youn et al., 2008). In other assays, sort purified monocytic
cells from day 14 C13 infection were cultured 1:2 with 105 purified and
CFSE-labeled CD8+ cells and stimulated with plate-bound anti-CD3ε and
anti-CD28 for 3 days. Inhibitors L-NIL (0.5 mM, Sigma-Aldrich), nor-NOHA
(0.5 mM, Cayman Chemical Company), and L-NMMA (5 mM, Calbiochem)
and blocking antibodies anti-IFN-g (XMG1.2, 10 mg/ml), anti-IL-10R (1B1.3a,
20 mg/ml, Biolegend), anti-PD1 (J43, 10 mg/ml, eBioscience), and anti-TGF-
b1,2,3 (1D11, 10 mg/ml, R&D Systems) were added at the beginning of culture.
Gene Expression Analyses
Total RNA from sorted splenic monocytic cells of naive and day 14 C13-in-
fected mice were purified with Trizol (Invitrogen). Relative gene expression
was enumerated with Illumina MouseWG-6 v2.0 Expression BeadChips.
Further details are in Supplemental Information.
Myeloid Cell Depletion
Mice infected with C13 were given intraperitoneal injections of 100 mg of anti-
Gr-1 (RB6-8C5) (Bio X Cell) or isotype control antibody at days 11, 12, and 13
p.i. Spleens, LNs, blood were collected on day 14.
Statistics
Statistical significance was determined by Mann-Whitney tests via Prism
(GraphPad Software). Probability values of p % 0.05 were considered
significant.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE43896.
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